Fine Foods & Pharmaceuticals Ntm Logo

Fine Foods & Pharmaceuticals Ntm

A CSDMO specializing in solid oral forms for the pharma and nutraceutical sectors.

FF | XMIL

Overview

Corporate Details

ISIN(s):
IT0005215329 (+1 more)
LEI:
8156009111DEE8553765
Country:
Italy
Address:
VIA BERLINO, 39 (ZINGONIA), 24040 VERDELLINO

Description

Fine Foods & Pharmaceuticals Ntm is an integrated Contract Sales and Development Manufacturing Organization (CSDMO) specializing in the development and contract manufacturing of products for third parties. The company's core expertise is in solid oral forms for the pharmaceutical and nutraceutical sectors. Its services also extend to the production of medical devices, cosmetics, and biocides. The organization applies a principle of scientific rigor across all its operations, emphasizing technological innovation, manufacturing excellence, and quality. With a significant portion of its workforce dedicated to science, the company acts as a strategic manufacturing partner to support client growth.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-04-08 12:31
AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA
Italian 236.3 KB
2022-04-01 08:58
Allegato 3F / Annex 3F
Italian 414.9 KB
2022-03-31 20:21
PUBBLICAZIONE DELLA RELAZIONE FINANZIARIA ANNUALE 2021,DNF E DOCUMENTAZIONE ASS…
Latin 274.1 KB
2022-03-31 17:41
RELAZIONE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI
Italian 953.0 KB
2022-03-31 17:38
Consolidated non-financial statement prepared under Legislative Decree no. 254/…
English 18.2 MB
2022-03-31 17:35
Dichiarazione consolidata di carattere non finanziario redatta ai sensi del D.L…
Italian 19.4 MB
2022-03-30 17:55
THE BOARD APPROVED THE 31 DECEMBER 2021 CONSOLIDATED FINANCIAL STATEMENTS
English 565.9 KB
2022-03-30 17:52
IL CDA APPROVA IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2021
Italian 524.9 KB
2022-03-14 14:51
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Italian 1.0 MB
2022-03-07 09:22
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Italian 1.0 MB
2022-03-01 10:55
Allegato 3F / Annex 3F
Italian 417.9 KB
2022-02-28 09:56
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Italian 1.0 MB
2022-02-25 20:05
SOTTOSCRITTO UN CONTRATTO DI FINANZIAMENTO A MEDIO LUNGO TERMINE PER UN IMPORTO…
Latin 301.9 KB
2022-02-21 10:19
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Italian 1.0 MB
2022-02-14 10:18
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE / TREASURY SHARES BUYBACK INFORMATION
Italian 1.0 MB

Automate Your Workflow. Get a real-time feed of all Fine Foods & Pharmaceuticals Ntm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fine Foods & Pharmaceuticals Ntm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fine Foods & Pharmaceuticals Ntm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.